Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2001 3
2002 13
2003 12
2004 25
2005 21
2006 29
2007 27
2008 23
2009 28
2010 23
2011 34
2012 37
2013 25
2014 23
2015 8
2016 13
2017 14
2018 14
2019 6
2020 10
Text availability
Article attribute
Article type
Publication date

Search Results

351 results
Results by year
Filters applied: . Clear all
Page 1
Treatment for Bipolar Disorder in Adults: A Systematic Review.
Butler M, Urosevic S, Desai P, Sponheim SR, Popp J, Nelson VA, Thao V, Sunderlin B. Butler M, et al. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Aug. Report No.: 18-EHC012-EF. Agency for Healthcare Research and Quality (US). 2018. PMID: 30329241 Free Books & Documents. Review.
All drug study findings with at least low-strength evidence were based almost exclusively on adults with bipolar I disorder (BD-I). ...Unpooled evidence indicated an overall beneficial effect of risperidone and ziprasidone on acute mania symptoms compared to placebo …
All drug study findings with at least low-strength evidence were based almost exclusively on adults with bipolar I disorder (BD-I). . …
A History of the Pharmacological Treatment of Bipolar Disorder.
López-Muñoz F, Shen WW, D'Ocon P, Romero A, Álamo C. López-Muñoz F, et al. Int J Mol Sci. 2018 Jul 23;19(7):2143. doi: 10.3390/ijms19072143. Int J Mol Sci. 2018. PMID: 30041458 Free PMC article. Review.
In this paper, the authors review the history of the pharmacological treatment of bipolar disorder, from the first nonspecific sedative agents introduced in the 19th and early 20th century, such as solanaceae alkaloids, bromides and barbiturates, to John Cade's expe …
In this paper, the authors review the history of the pharmacological treatment of bipolar disorder, from the first nonspecific sedati …
Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
Taylor DM, Cornelius V, Smith L, Young AH. Taylor DM, et al. Acta Psychiatr Scand. 2014 Dec;130(6):452-69. doi: 10.1111/acps.12343. Epub 2014 Oct 6. Acta Psychiatr Scand. 2014. PMID: 25283309 Review.
METHOD: We performed a multiple-treatments meta-analysis of randomised, double-blind, controlled comparisons of 4-16 weeks in adults in bipolar depression. ...Several treatments [monoamine oxidase inhibitors (MAOIs), ziprasidone, aripiprazole and risperidone] have l …
METHOD: We performed a multiple-treatments meta-analysis of randomised, double-blind, controlled comparisons of 4-16 weeks in adults in b
Safety considerations in the psychopharmacology of pediatric bipolar disorder.
Sun AY, Woods S, Findling RL, Stepanova E. Sun AY, et al. Expert Opin Drug Saf. 2019 Sep;18(9):777-794. doi: 10.1080/14740338.2019.1637416. Epub 2019 Jul 11. Expert Opin Drug Saf. 2019. PMID: 31242784 Review.
Introduction: The standard of treatment of pediatric bipolar disorder (BPD) often requires life-long psychopharmacological management. ...Studies of ziprasidone, aripiprazole and lurasidone do not suggest significant metabolic AEs. More studies are needed to assess …
Introduction: The standard of treatment of pediatric bipolar disorder (BPD) often requires life-long psychopharmacological management …
Ziprasidone.
[No authors listed] [No authors listed] 2020 Jul 1. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012–. PMID: 31643974 Free Books & Documents. Review.
Ziprasidone is an atypical antipsychotic used in the treatment of schizophrenia and bipolar disorder. Use of ziprasidone has not been consistently associated with serum enzyme elevations and has yet to be linked to instances of clinically apparent acute liver
Ziprasidone is an atypical antipsychotic used in the treatment of schizophrenia and bipolar disorder. Use of ziprasidone
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder.
Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Azorin JM, Yatham L, Mosolov S, Möller HJ, Kasper S; Members of the WFSBP Task Force on Bipolar Affective Disorders Working on this topic. Grunze H, et al. World J Biol Psychiatry. 2018 Feb;19(1):2-58. doi: 10.1080/15622975.2017.1384850. Epub 2017 Nov 3. World J Biol Psychiatry. 2018. PMID: 29098925 Review.
For depressive symptoms, addition of ziprasidone to treatment as usual may be beneficial; however, the evidence base is much more limited than for the treatment of manic symptoms. ...As a consequence, studies in bipolar mixed patients targeted slightly different …
For depressive symptoms, addition of ziprasidone to treatment as usual may be beneficial; however, the evidence base is much more lim …
Maintenance therapy with second generation antipsychotics for bipolar disorder - A systematic review and meta-analysis.
Lindström L, Lindström E, Nilsson M, Höistad M. Lindström L, et al. J Affect Disord. 2017 Apr 15;213:138-150. doi: 10.1016/j.jad.2017.02.012. Epub 2017 Feb 14. J Affect Disord. 2017. PMID: 28222360 Review.
LIMITATIONS: There were considerable limitations to the evidence base of maintenance treatment with SGA in bipolar disorder. ...No long-term RCT data on efficacy is available beyond 2 years, and almost all studies are on bipolar disorder type I patients only. ...
LIMITATIONS: There were considerable limitations to the evidence base of maintenance treatment with SGA in bipolar disorder. ...No lo …
Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis.
Ostacher M, Ng-Mak D, Patel P, Ntais D, Schlueter M, Loebel A. Ostacher M, et al. World J Biol Psychiatry. 2018 Dec;19(8):586-601. doi: 10.1080/15622975.2017.1285050. Epub 2017 Mar 7. World J Biol Psychiatry. 2018. PMID: 28264635
METHODS: Fourteen randomised clinical trials (6221 patients) of lurasidone, quetiapine (extended release and immediate release), aripiprazole, olanzapine, and ziprasidone for bipolar depression were included. Efficacy assessments included change in the Montgomery-Ås …
METHODS: Fourteen randomised clinical trials (6221 patients) of lurasidone, quetiapine (extended release and immediate release), aripiprazol …
A Focused Review on the Treatment of Pediatric Patients with Atypical Antipsychotics.
Lee ES, Vidal C, Findling RL. Lee ES, et al. J Child Adolesc Psychopharmacol. 2018 Nov;28(9):582-605. doi: 10.1089/cap.2018.0037. Epub 2018 Oct 12. J Child Adolesc Psychopharmacol. 2018. PMID: 30312108 Review.
A PubMed search was conducted for each of the 11 second-generation antipsychotic medications currently approved by the Food and Drug Administration for use in the United States: clozapine, risperidone, olanzapine, quetiapine, aripiprazole, ziprasidone, paliperidone, asenap …
A PubMed search was conducted for each of the 11 second-generation antipsychotic medications currently approved by the Food and Drug Adminis …
Ziprasidone in bipolar disorder.
Versiani M. Versiani M. Expert Opin Pharmacother. 2006 Jun;7(9):1221-8. doi: 10.1517/14656566.7.9.1221. Expert Opin Pharmacother. 2006. PMID: 16732708
The efficacy of ziprasidone in bipolar mania (current episode, manic or mixed) has been well demonstrated in three placebo-controlled trials. ...Ziprasidone was very well tolerated by patients with bipolar disorder and did not cause increased weight, g …
The efficacy of ziprasidone in bipolar mania (current episode, manic or mixed) has been well demonstrated in three placebo-con …
351 results
Jump to page
Feedback